Phylloceuticals2
Phylloceuticals2
  • Home
  • Our Team
    • OUR TEAM
    • Bill Brydges, M.S.
    • Dan Hanson, M.S.
    • R. Barry Holtz, Ph.D.
    • Susan Stipa
    • Lynn Dickey, Ph.D.
    • Curt Cornwell
    • Kathleen Brunner
    • Mark Brown, Ph.D.
  • Technology
  • Markets
  • News
    • News
    • Phylloside Chats
    • Press Release
  • Contact Us
  • More
    • Home
    • Our Team
      • OUR TEAM
      • Bill Brydges, M.S.
      • Dan Hanson, M.S.
      • R. Barry Holtz, Ph.D.
      • Susan Stipa
      • Lynn Dickey, Ph.D.
      • Curt Cornwell
      • Kathleen Brunner
      • Mark Brown, Ph.D.
    • Technology
    • Markets
    • News
      • News
      • Phylloside Chats
      • Press Release
    • Contact Us
  • Home
  • Our Team
  • Technology
  • Markets
  • News
  • Contact Us

Our Team

This is the Phylloceuticals team. The team has been working on projects together for decades, and now are coming together to provide the PhAAST™ platform to clients around the globe.


From early stage funding, drug discovery and development, regulatory strategy, to engineering and construction, the ‘dream team’ at Phylloceuticals is sought out globally for their unique blend of expertise. 

WHO WE ARE




Bill Brydges, M.S.




Dan Hanson, M.S.


 


R. Barry Holtz




Susan Stipa




Lynn Dickey, Ph.D.




Curt Cornwell




Kathleen Brunner




Mark Brown, Ph.D.
  • Home
  • Terms and Conditions